SCHEMBL16456367

SCHEMBL16456367

CCc1ccc(C(=O)Nc2cccc3cccnc23)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.73
KMT2A Q03164 1/20 0.73
HDAC6 Q9UBN7 5/20 0.71
KDR P35968 4/20 0.71
TDP1 Q9NUW8 1/20 0.70
GAA P10253 1/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
MAPT P10636 4/20 0.69
TP53 P04637 2/20 0.69
SMN1; SMN2 Q16637 1/20 0.65
NPC1 O15118 2/20 0.65
RAB9A P51151 2/20 0.65
CASP3 P42574 1/20 0.65
SENP8 Q96LD8 1/20 0.65
SENP7 Q9BQF6 1/20 0.65
SENP6 Q9GZR1 1/20 0.65
KDM4E B2RXH2 1/20 0.65
HDAC3 O15379 4/20 0.62
HDAC1 Q13547 4/20 0.62
HDAC2 Q92769 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18668668 0.88 HDAC6 (0.73) POLBKMT2AHDAC6KDRTDP1
SCHEMBL24522646 0.86 HDAC6 (0.74) POLBKMT2AHDAC6KDRTDP1
SCHEMBL19631308 0.86 KMT2A (0.71) POLBKMT2AHDAC6KDRTDP1
SCHEMBL19616631 0.85 HDAC6 (0.73) POLBKMT2AHDAC6KDRTDP1
SCHEMBL16456332 0.85 HDAC6 (0.77) POLBKMT2AHDAC6KDRTDP1
SCHEMBL29655132 0.85 HDAC6 (0.77) POLBKMT2AHDAC6KDRTDP1
SCHEMBL19616636 0.85 KMT2A (0.70) POLBKMT2AHDAC6KDRTDP1
SCHEMBL18668657 0.84 KDR (0.70) POLBKMT2AHDAC6KDRTDP1
SCHEMBL19617433 0.84 HDAC6 (0.74) POLBKMT2AHDAC6KDRTDP1
SCHEMBL19631488 0.83 HDAC6 (1.00) POLBKMT2AHDAC6KDRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111519204-B Method for preparing N- (5-chloro-8-quinolyl) benzamide compound by adopting electrochemical microchannel reaction device 南京工业大学 2021-06-29 CN disclosed
CN-111423372-B Method for preparing N- (5-hydroxyquinoline-8-yl) benzamide compound by electrochemical microchannel reaction device 南京工业大学 2021-04-27 CN disclosed
CN-111519204-A Method for preparing N- (5-chloro-8-quinolyl) benzamide compound by adopting electrochemical microchannel reaction device 南京工业大学 2020-08-11 CN disclosed
CN-109320497-B Method for preparing phenanthridinone compound by copper compound induction 广州大学 2020-07-31 CN disclosed
CN-111423372-A Method for preparing N- (5-hydroxyquinoline-8-yl) benzamide compound by electrochemical microchannel reaction device 南京工业大学 2020-07-17 CN disclosed
CN-109320497-A A method of phenanthridines ketone compounds are prepared by copper compound induction 广州大学 2019-02-12 CN disclosed
US-9340549-B2 Oxazolidinone compounds and derivatives thereof AMGEN INC. (US) 2016-05-17 US disclosed
US-20150045368-A1 OXAZOLIDINONE COMPOUNDS AND DERIVATIVES THEREOF AMGEN INC. 2015-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045368-A1 OXAZOLIDINONE COMPOUNDS AND DERIVATIVES THEREOF TNKS1BP1, TNKS, TBKBP1 POLB 172/4885KMT2A 2435/4885HDAC6 785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.